Elena PETELOS

Elena Petelos is a Senior Research Fellow in Public Health and a Lecturer in Evidence-Based Medicine and Evidence-Informed Policy (Maastricht University, The Netherlands, and University of Crete, Greece). She also holds Visiting Lecturer and Adjunct Faculty positions (Charité-Universitätsmedizin Berlin, Germany, and University of West Attica, Greece). She has a background in medicine and biology, specialising in molecular oncology, and re-training mid-career in health economics and policy, continuing with a Fellowship in Governance and Economics of Development Technology and Innovation at the United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology.

She currently also serves as the President for Global Health and VP HTA at the European Public Health Association (EUPHA), where she is also a Member of the Steering Committee of the Law and Public Health Section, and the Chair of the Gender Equality Working Group (SDG5 WG). She is the Co-Chair for Real-World Evidence and Artificial Intelligence (AI) at HTAi, and also Co-Chairs the HTAi-INAHTA Glossary Committee. She is also a Member of the Healthcare Professional’s Working Party of the European Medicines Agency (EMA) and a Member of the Advisory Forum of the Health Emergency Preparedness and Response (HERA) of the European Commission. She is a Member of the Advisory Board of the European Forum for Primary Care (EFPC) leading the Vaccines WG and representing it in the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP); she is currently a member of ENCEPP’s WG2 on Transparency and Independent Research. She also represents EFPC and EUPHA in the European Commission’s HTA Network Stakeholder Expert Pool. She has served in various committees of the World Health Organization (WHO), and as of 2024, she co-chairs the Strategic Partners’ Initiative for Data and Digital Health (SPI-DDH) WG on Digitalization and Responsible AI.

Her research, policy and advocacy work focuses on international collaboration, including regulatory frameworks and legislative frameworks, to improve global health and towards achieving digital equity and reaching UHC, with special emphasis on real-world evidence, benefit/risk communication, new technologies, and AI. She is also a member of the Royal Netherlands Society of International Law (KNVIR) and of the International Law Association (ILA).